OAS1 has also been recently implicated in cancer cell survival after treatment with DNA damaging agents (44) and in mediating the cytotoxicity of 5-azacytidine (AZA), a DNA methyltransferase inhibitor widely used in cancer treatment (45). This evidence concerns the gene OAS1 and cancer.